Keap1–Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics

por Tong, Ying-Hui, Zhang, Bo, Fan, Yun, Lin, Neng-Ming
Publicado en Chronic Dis Transl Med (2015)

Synergistic antitumor activity of aspirin and erlotinib: Inhibition of p38 enhanced aspirin plus erlotinib-induced suppression of metastasis and promoted cancer cell apoptosis

por Hu, Xiu, Wu, Lin-Wen, Weng, Xu, Lin, Neng-Ming, Zhang, Chong
Publicado en Oncol Lett (2018)

S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro

por Xu, Ya-si, Feng, Jian-guo, Zhang, Dan, Zhang, Bo, Luo, Min, Su, Dan, Lin, Neng-ming
Publicado en Acta Pharmacol Sin (2014)

BAY 87-2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK-3β activation

por Li, Yang-Ling, Rao, Ming-Jun, Zhang, Ning-Yu, Wu, Lin-Wen, Lin, Neng-Ming, Zhang, Chong
Publicado en Exp Ther Med (2019)

Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas

por Fan, Yun, Lin, Neng-ming, Luo, Lü-hong, Fang, Luo, Huang, Zhi-yu, Yu, Hai-feng, Wu, Feng-qin
Publicado 2011

Nedaplatin enhanced apoptotic effects of ABT-737 in human cancer cells via Mcl-1 inhibition

por Zhang, Chong, Li, Yang-Ling, Weng, Xu, Li, Li-Yan, Zhou, Ming-Xian, Zhang, Da-Yong, Lin, Neng-Ming
Publicado en Oncol Lett (2016)

DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild‐type NSCLC cells to AZD9291

por Li, Yang‐ling, Ding, Ke, Hu, Xiu, Wu, Lin‐wen, Zhou, Dong‐mei, Rao, Ming‐jun, Lin, Neng‐ming, Zhang, Chong
Publicado en J Cell Mol Med (2019)

A novel derivative of valepotriate inhibits the PI3K/AKT pathway and causes Noxa-dependent apoptosis in human pancreatic cancer cells

por Yan, You-you, Shi, Ke-yu, Teng, Fei, Chen, Jing, Che, Jin-xin, Dong, Xiao-wu, Lin, Neng-ming, Zhang, Bo
Publicado en Acta Pharmacol Sin (2020)

Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer

por Fan, Yun, Lin, Neng-ming, Ma, Sheng-lin, Luo, Lü-hong, Fang, Luo, Huang, Zhi-yu, Yu, Hai-feng, Wu, Feng-qin
Publicado 2010

Shikonin sensitizes wild-type EGFR NSCLC cells to erlotinib and gefitinib therapy

por Li, Yang-Ling, Hu, Xiu, Li, Qing-Yu, Wang, Fei, Zhang, Bo, Ding, Ke, Tan, Bi-Qin, Lin, Neng-Ming, Zhang, Chong
Publicado en Mol Med Rep (2018)

In vitro anti-cancer activity of chamaejasmenin B and neochamaejasmin C isolated from the root of Stellera chamaejasme L

por Zhang, Chong, Zhou, Shuang-shuang, Feng, Lin-yi, Zhang, Da-yong, Lin, Neng-ming, Zhang, Li-huang, Pan, Jian-ping, Wang, Jun-bo, Li, Jie
Publicado 2013

Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer

por Tong, Ying-Hui, Zhang, Bo, Yan, You-You, Fan, Yun, Yu, Jia-Wen, Kong, Si-Si, Zhang, Dan, Fang, Luo, Su, Dan, Lin, Neng-Ming
Publicado en Oncotarget (2017)

Deacetylisovaltratum disrupts microtubule dynamics and causes G(2)/M-phase arrest in human gastric cancer cells in vitro

por Zhang, Dan, Zhang, Bo, Zhou, Li-xin, Zhao, Jun, Yan, You-you, Li, Yang-ling, Zeng, Jian-mei, Wang, Lin-ling, Yang, Bo, Lin, Neng-ming
Publicado en Acta Pharmacol Sin (2016)

Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737

por Zhang, Chong, Shi, Jing, Mao, Shi-ying, Xu, Ya-si, Zhang, Dan, Feng, Lin-yi, Zhang, Bo, Yan, You-you, Wang, Si-cong, Pan, Jian-ping, Yang, You-ping, Lin, Neng-ming
Publicado en J Cell Mol Med (2015)